Labcorp to announce fourth quarter and full year 2022 financial results on February 16, 2023

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 18, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the fourth quarter and full year 2022 before the market opens on Thursday, Feb. 16, 2023 . The company will host a conference call and webcast

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 12, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 13, 2023 , to stockholders of record as

Tom Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit

Mr. Pike Brings 30 Years of Industry Experience and a Proven Track Record of Driving Growth 

Labcorp to speak at the 41st Annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m.

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in

Statement regarding Cambodian NHP supply

The November 16, 2022, indictment filed against the Cambodian breeder and Cambodian officials does not name or reference Labcorp.  The Early Development business has multiple global suppliers and requires its vendors to meet high regulatory compliance standards.  Ex-US sites do not use Cambodian NHP supply. The business is working to procure additional supply from other sources for our US operations. US NHP studies comprise less than 2% of overall enterprise Labcorp revenue.  

How one company used lab data insights to improve population management of chronic kidney disease (CKD)

When one of New Jersey’s largest independent physician associations (IPA) entered into a value-based care contract, they intensified their focus on identifying and managing their chronic kidney disease (CKD) population with a few goals in mind:

Labcorp announces 2022 third quarter results

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 27, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022 , and updated full-year guidance.

Labcorp appoints Google Cloud executive Kirsten Kliphouse to its Board of Directors

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 13, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse , president of Americas , Google Cloud, has joined its Board of Directors as an independent member. This press release features multimedia.

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 12, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022.